Hong Kong Science and Technology Parks Corporation: HKSTP and Boehringer Ingelheim Venture Fund Launch Co-Incubation Programme to Fast-track R&D in Infectious Diseases and Immunology

Hong Kong Science and Technology Parks Corporation (HKSTP) is partnering global research-driven biopharmaceutical leader, Boehringer Ingelheim Venture Fund Limited (BIVF) in a strategic co-incubation

Related Keywords

China ,Yuen Long ,Hong Kong General ,Hong Kong ,Shatin ,Macau ,Karmen Cheung ,Frank Kalkbrenner ,Felix Gutsche ,Tseung Kwan ,Guangdong Hong Kong ,Albert Wong ,Bio Comms ,Technology Parks Corporation ,Venture Fund ,Head Of Institute ,Boehringer Ingelheim ,Incu Bio Programme ,Business Development Licensing ,Boehringer Ingelheim Venture Fund ,Research Beyond Borders ,Institute For Translational Research ,Boehringer Ingelheim Venture Fund Limited ,Boehringer Ingelheim Venture Fund Gmb ,Translational Research ,Hong Kong Science ,Grace Lau ,Global Head ,External Innovation Hub ,Guangdong Hong Kong Macau Greater Bay Area ,Science Park ,Technology Parks ,Kong Science ,Greater Bay Area ,Hong Kong Science Park ,Kowloon Tong ,Boehringer Ingelheim Venture Fund Gmbh ,Hong ,Song ,Science ,Technology ,Parks ,Corporation ,Hkstp ,Boehringer ,Ingelheim ,Venture ,Fund ,Launch ,Incubation ,Programme ,Mast ,Track ,Nfectious ,Diseases ,Mmunology ,